BACKGROUND: The treatment of Multidrug-Resistant Tuberculosis represents one of the most significant challenges to global health. Despite guidance on improving treatment outcomes, there is little focus on how to support individuals in their suffering. Palliative care is therefore proposed as a necessary component in the global strategy to fight Tuberculosis. We aim to describe the informal resources and networks available to persons affected by Multidrug-Resistant Tuberculosis, how they are accessed and how they are integrated into everyday lives. METHODS: In-depth ethnographic research was conducted in Bengaluru, India. Informal interactions and observations were recorded across a range of palliative care and tuberculosis treatment provide...
The purpose of this research study was to explore and describe the experiences of patients on short-...
Background: India's Revised National Tuberculosis (TB) Control Programme (RNTCP) offers free TB diag...
Background: India has largest population of drug resistant tuberculosis, the treatment of which is l...
Abstract Background The treatment of Multidrug-Resistant Tuberculosis represents one of the most sig...
The treatment and prevention of multidrug resistant tuberculosis (MDR TB) is a significant public he...
Includes bibliographical references.Although curable, tuberculosis (TB) remains a serious health car...
Background: People with multi-drug resistant tuberculosis (MDR-TB) in low-income countries face many...
Background: In India, the Revised National TB control programme (RNTCP) offers free diagnosis and tr...
Background: In Nigeria multidrug-resistant tuberculosis (MDR-TB) is prevalent in 2.9% of new TB case...
INTRODUCTION : The emergence of resistance to drugs used to treat tuberculosis (TB), and particular...
Nowadays, the medical approach over still dominating and hegemonies in overcoming tuberculosis (TB),...
Tuberculosis remains a worldwide public health problem. India has the highest burden of tuberculosis...
Background: Tuberculosis is the most common cause of death from an infectious disease worldwide afte...
Multi-drug-resistant tuberculosis (MDR-TB) poses a major threat to public health worldwide, particul...
Non-completion of tuberculosis (TB) treatment has been a major topic of debate ever since combined d...
The purpose of this research study was to explore and describe the experiences of patients on short-...
Background: India's Revised National Tuberculosis (TB) Control Programme (RNTCP) offers free TB diag...
Background: India has largest population of drug resistant tuberculosis, the treatment of which is l...
Abstract Background The treatment of Multidrug-Resistant Tuberculosis represents one of the most sig...
The treatment and prevention of multidrug resistant tuberculosis (MDR TB) is a significant public he...
Includes bibliographical references.Although curable, tuberculosis (TB) remains a serious health car...
Background: People with multi-drug resistant tuberculosis (MDR-TB) in low-income countries face many...
Background: In India, the Revised National TB control programme (RNTCP) offers free diagnosis and tr...
Background: In Nigeria multidrug-resistant tuberculosis (MDR-TB) is prevalent in 2.9% of new TB case...
INTRODUCTION : The emergence of resistance to drugs used to treat tuberculosis (TB), and particular...
Nowadays, the medical approach over still dominating and hegemonies in overcoming tuberculosis (TB),...
Tuberculosis remains a worldwide public health problem. India has the highest burden of tuberculosis...
Background: Tuberculosis is the most common cause of death from an infectious disease worldwide afte...
Multi-drug-resistant tuberculosis (MDR-TB) poses a major threat to public health worldwide, particul...
Non-completion of tuberculosis (TB) treatment has been a major topic of debate ever since combined d...
The purpose of this research study was to explore and describe the experiences of patients on short-...
Background: India's Revised National Tuberculosis (TB) Control Programme (RNTCP) offers free TB diag...
Background: India has largest population of drug resistant tuberculosis, the treatment of which is l...